ARWR Arrowhead Pharmaceuticals, Inc.

41.37USD-5.22%Mkt Cap: 5.85B USDP/E: —

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasir…